Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Statement on “Most-Favored-Nation” Executive Order
HDA released a statement in response to President Donald J. Trump’s Executive Order establishing a “Most-Favored-Nation” (MFN) pricing policy for pharmaceuticals.
HDA Honors Rx and Consumer Product Manufacturers With DIANA Awards
The Healthcare Distribution Alliance (HDA) honored 10 pharmaceutical and consumer product manufacturers with Distribution Industry Awards for Notable Achievements in Healthcare (DIANA Awards) at the 2025 HDA Business and Leadership Conference in Orlando, Fla.
HDA Announces Government Affairs and Policy Staffing Updates
The Healthcare Distribution Alliance (HDA) announces updates regarding staff leading its Government Affairs and Policy teams.
HDA Statement on Drug Shortages
Healthcare Distribution Alliance (HDA) President and CEO Chip Davis released the following statement in response to the Senate Finance Committee hearing entitled, “Drug Shortages: Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective.”
HDA Statement on Senate Confirmation of Dr. Marty Makary As FDA Commissioner
The Healthcare Distribution Alliance (HDA) released the following statement on the U.S. Senate’s vote to confirm Dr. Marty Makary as the Food and Drug Administration (FDA) Commissioner.